Literature DB >> 20066394

[Use of PET and SPECT in psychiatry].

G Gründer1, I Vernaleken, P Bartenstein.   

Abstract

This review presents the basic essentials of the application of nuclear medicine technology in psychiatry, i.e., positron emission tomography (PET) and single photon emission computed tomography (SPECT). These include integral principles of physics and radiochemistry as well as of data acquisition and analysis. Significant findings from applications in research and the clinical setting (schizophrenic and affective disorders, substance abuse, dementia) illustrate the huge potential of these methods. They have helped to deepen the understanding of the neurobiology of those disorders and the mechanism of action of psychotropic drugs. Due to its unmatched sensitivity, molecular imaging with PET and SPECT represents an important complement to magnetic resonance imaging technology in research and clinical practice.

Entities:  

Mesh:

Year:  2010        PMID: 20066394     DOI: 10.1007/s00115-009-2830-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  15 in total

1.  PET of brain amyloid and tau in mild cognitive impairment.

Authors:  Gary W Small; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Susan Y Bookheimer; Karen J Miller; Helen Lavretsky; Alison C Burggren; Greg M Cole; Harry V Vinters; Paul M Thompson; S-C Huang; N Satyamurthy; Michael E Phelps; Jorge R Barrio
Journal:  N Engl J Med       Date:  2006-12-21       Impact factor: 91.245

2.  PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.

Authors:  Johan Lundberg; Jacob Strøyer Christophersen; Kamilla Buchberg Petersen; Henrik Loft; Christer Halldin; Lars Farde
Journal:  Int J Neuropsychopharmacol       Date:  2007-01-04       Impact factor: 5.176

3.  Opioid receptor PET reveals the psychobiologic correlates of reward processing.

Authors:  Mathias Schreckenberger; André Klega; Gerhard Gründer; Hans-Georg Buchholz; Armin Scheurich; Ralf Schirrmacher; Esther Schirrmacher; Christina Müller; Gjermund Henriksen; Peter Bartenstein
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

4.  Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.

Authors:  J H Meyer; A A Wilson; N Ginovart; V Goulding; D Hussey; K Hood; S Houle
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

5.  Relationship between subjective effects of cocaine and dopamine transporter occupancy.

Authors:  N D Volkow; G J Wang; M W Fischman; R W Foltin; J S Fowler; N N Abumrad; S Vitkun; J Logan; S J Gatley; N Pappas; R Hitzemann; C E Shea
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

Review 6.  Imaging the neurochemistry of alcohol and substance abuse.

Authors:  Diana Martinez; Jong-Hoon Kim; John Krystal; Anissa Abi-Dargham
Journal:  Neuroimaging Clin N Am       Date:  2007-11       Impact factor: 2.264

7.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.

Authors:  Lisa Mosconi; Rachel Mistur; Remigiusz Switalski; Wai Hon Tsui; Lidia Glodzik; Yi Li; Elizabeth Pirraglia; Susan De Santi; Barry Reisberg; Thomas Wisniewski; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236

8.  Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.

Authors:  Gerhard Gründer; Christine Fellows; Hildegard Janouschek; Tanja Veselinovic; Christian Boy; Anno Bröcheler; Katrin M Kirschbaum; Sandra Hellmann; Katja M Spreckelmeyer; Christoph Hiemke; Frank Rösch; Wolfgang M Schaefer; Ingo Vernaleken
Journal:  Am J Psychiatry       Date:  2008-04-01       Impact factor: 18.112

9.  Seasonal variation in human brain serotonin transporter binding.

Authors:  Nicole Praschak-Rieder; Matthaeus Willeit; Alan A Wilson; Sylvain Houle; Jeffrey H Meyer
Journal:  Arch Gen Psychiatry       Date:  2008-09

10.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.